R Bassan, E Pogliani, T Lerede, P Fabris, G Rossi, S Morandi, P Casula, G Lambertenghi-Deliliers, M Vespignani, T Izzi, P Coser, G Corneo, T Barbui. Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study. Haematologica 1999;84(12):1088-1093; https://doi.org/10.3324/%x.